Skip to main content

Table 1 Clinicopathological characteristics of the patients

From: Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients

Clinicopathological characteristics No (%)
All patients 104 (100.0)
Age in years (21–79)
 mean: 56.5 ± 15.4; median: 58.5  
Gender
 Female 60 (57.7)
 Male 44 (42.3)
Primary tumor location
 Head/neck 15 (14.4)
 Upper extremity 18 (17.3)
 Lower extremity 25 (24.0)
 Trunk 42 (40.4)
 Hand/foot 4 (3.8)
Primary tumor (pT)
 pT1 34 (32.7)
 pT2 20 (19.2)
 pT3 27 (26.0)
 pT4 23 (22.1)
Sentinel lymph node biopsy status (SNLB) 60 (57.7)
 No metastases (SNLB-) 48 (80.0)
 Metastases present (SNLB+) 12 (20.0)
Regional lymph nodes status (pN)  
 No metastases (pN-) 86 (82.7)
 Metastases present (pN+) 18 (17.3)
Recurrence
 No 87 (83.7)
 Yes 17 (16.3)
Distant metastases
 No 99 (95.2)
 Yes 5 (4.8)